HealthSprint 2026: Indo-Israel Innovation Sprint for Healthcare Startups
By GINSERV
Check your eligibility
Sign up and we'll tell you whether your startup qualifies for this grant.
Quick Answer
A 30-day Indo-Israel Innovation Sprint for high-potential Healthcare and MedTech startups to become investment-ready and globally connected.
- Funding amount
- Varies
- Funding type
- Competition
- Provider
- GINSERV
- Application deadline
- Closed
- Location
- Karnataka, Tamil Nadu, Kerala, Puducherry
Results & next round
Applications for this round closed on 20 July 2026. The organiser has not published a selection list that we can verify yet.
Selections for this programme are announced by GINSERV. Official links are listed under Sources below.
We update this page when results are published, and when the next round opens.
About this competition
HealthSprint 2026 is an intensive 30-day innovation sprint specifically crafted for promising Healthcare and MedTech startups. This unique Indo-Israel collaboration aims to accelerate the growth of participating startups by providing them with unparalleled access to global healthcare innovation ecosystems, expert mentorship, and critical hospital networks. The program is designed to transform high-potential ventures into investment-ready entities, equipping them with the strategic insights and connections needed to scale internationally. By focusing on critical areas such as Clinical AI & Diagnostics, MedTech & Point-of-Care Devices, and Hospital SaaS & Managed Care Platforms, HealthSprint 2026 seeks to foster groundbreaking solutions that address pressing global health challenges. The sprint offers a comprehensive support system, including a sponsored visit to Israel, allowing startups to immerse themselves in one of the world's leading health technology hubs. Participants will gain a competitive edge through direct engagement with a vibrant ecosystem of innovators, investors, and industry leaders from both India and Israel, paving the way for significant market expansion and impact.
Eligibility
See if you're eligible
Full eligibility criteria — entity type, stage, sector, founder profile and registration requirements — plus your fit for this program. Sign up to view.
Organizers
GINSERV is a technology business incubator and accelerator in Bengaluru, founded in 2010 under JSS Mahavidyapeetha, an education trust that runs over 300 institutions across India. It works out of a 55,000 sq. ft. campus in Kodihalli, behind The Leela Palace, about 15 minutes…
Learn morePrizes & Awards
What You Get
- Sponsored visit to Israel: Fully funded trip for immersion in Israel's healthtech innovation ecosystem.
- 30-day Indo-Israel sprint: Intensive collaboration with Israeli healthtech experts for product development acceleration.
- Global exposure: Opportunity to showcase at an international forum and pitch to global investors.
- Industry networking: Connections to Israeli healthtech companies, research institutions, and potential partners.
- Duration
- 1 months
- Cohort size
- 15 startups
- Bootstrap friendly
- Yes
Timelines & Process
Selection Process
The selection process for HealthSprint 2026 is highly competitive, designed to identify the 15 most promising Healthcare and MedTech startups. Applications will first be reviewed by an expert panel from Ginserv and its partners, evaluating criteria such as the innovativeness of the solution, the strength and experience of the founding team, market potential, alignment with focus areas, and readiness for investment and international scaling. Shortlisted startups will then be invited to participate in a series of in-depth interviews and potentially present their solutions to a high-level jury comprising industry veterans, investors, and healthcare experts from both India and Israel. The final cohort will be selected based on their potential for significant impact, technological readiness, and ability to leverage the sprint's benefits for accelerated growth.
Application Process
- 1
Apply Online
Submit your detailed application through the Ginserv portal, including all required documents.
You - 2
- 3
- 4
- 5
How to apply
Four steps from draft to disbursement — one action each.
- 1
See the questions before you start
Download every question this programme's application form asks, so you can prepare your answers offline before opening the portal.
- 2
Submit on the official portal
Use the official application link and verify all details before final submission.
- 3
Follow up
Reach out 5–7 days after submitting to confirm receipt and ask about the review timeline.
Frequently Asked Questions
What is the primary goal of HealthSprint 2026?
HealthSprint 2026 aims to accelerate high-potential Healthcare and MedTech startups, making them investment-ready and globally connected through an intensive 30-day Indo-Israel innovation program.
Which types of startups are eligible to apply?
The program is open to HealthTech and MedTech startups from Karnataka, Tamil Nadu, Kerala, and Puducherry. Applicants must be post-MVP (TRL 6+) and in early revenue stages, demonstrating readiness to scale.
What kind of financial support does the program offer?
HealthSprint 2026 does not provide direct financial grants or equity investments. Instead, it offers a fully sponsored visit to Israel, extensive mentorship, market access, and significant investor engagement opportunities to help startups secure external funding.
What are the key benefits for selected startups?
Selected startups will receive a sponsored trip to Israel, exposure to global healthcare innovation, access to hospital networks via the JSS network, dedicated investor engagement sessions, networking with ecosystem leaders, and mentorship from Israeli HealthTech experts.
Is there a specific deadline for applications?
Yes, the application deadline for HealthSprint 2026 is July 20, 2026. Interested startups are encouraged to apply well before this date.
How many startups will be selected for the sprint?
A highly competitive selection process will result in only 15 high-potential startups being chosen to participate in the HealthSprint 2026 cohort.
Sources
Data on this page is compiled from official program and provider references.
